World Health Organization OKs Multi-dose Maternal RSV Vaccine
The new multi-dose RSV vial is expected to lower costs and simplify global distribution to protect infants from severe respiratory illness.
The new multi-dose RSV vial is expected to lower costs and simplify global distribution to protect infants from severe respiratory illness.
Updated formulas from Pfizer, Moderna, and Novavax target the circulating XFG variant for older adults and high-risk populations.
The National Foundation for Infectious Diseases (NFID) launched an initiative to streamline evidence-based information regarding respiratory disease prevention.
Researchers have identified the first human case of swine influenza A(H1N2)v in mainland China, likely a domestic pig transmission to a rural child.
Merck is seeking expand approval for its RSV drug Enflonsia to include children under age two through their second year of risk.
A national study finds significant inconsistency among doctors when interpreting lung sounds in children suspected of pediatric pneumonia.